smscall
logo
Medical Care

Published On: Feb 10, 2025

Stem Cells Industry Research Report 2025

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 132 Pages
  • 2 Views

Version Type

$2,950.00

Summary
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
According to APO Research, The global Stem Cells market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Stem Cells is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Stem Cells is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Stem Cells Segment by Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells Segment by Application
Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells Segment by Application
Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table 1:Secondary Sources
Table 2:Primary Sources
Table 3:Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4:Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5:Global Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 6:Global Stem Cells Revenue Market Share by Type (2020-2025)
Table 7:Global Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 8:Global Stem Cells Revenue Market Share by Type (2026-2031)
Table 9:Global Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 10:Global Stem Cells Revenue Market Share by Application (2020-2025)
Table 11:Global Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 12:Global Stem Cells Revenue Market Share by Application (2026-2031)
Table 13:Global Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14:Global Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 15:Global Stem Cells Market Share by Region (2020-2025)
Table 16:Global Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17:Global Stem Cells Market Share by Region (2026-2031)
Table 18:Stem Cells Industry Trends
Table 19:Stem Cells Industry Drivers
Table 20:Stem Cells Industry Opportunities and Challenges
Table 21:Stem Cells Market Restraints
Table 22:Global Top Stem Cells Players by Revenue (US$ Million) & (2020-2025)
Table 23:Global Stem Cells Revenue Market Share by Players (2020-2025)
Table 24:Global Stem Cells Industry Players Ranking, 2023 VS 2024 VS 2025
Table 25:Global Key Players of Stem Cells, Headquarters and Area Served
Table 26:Global Stem Cells Players, Product Type & Application
Table 27:Global Players Market Concentration Ratio (CR5 and HHI)
Table 28:Global Stem Cells by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 29:Players Mergers & Acquisitions, Expansion Plans
Table 30:North America Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31:North America Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 32:North America Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 33:Europe Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34:Europe Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 35:Europe Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 36:Asia Pacific Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 37:Asia Pacific Stem Cells Market Size by Region (2020-2025) & (US$ Million)
Table 38:Asia Pacific Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 39:South America Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 40:South America Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 41:South America Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 42:Middle East & Africa Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43:Middle East & Africa Stem Cells Market Size by Country (2020-2025) & (US$ Million)
Table 44:Middle East & Africa Stem Cells Market Size by Country (2026-2031) & (US$ Million)
Table 45:Osiris Therapeutics Company Information
Table 46:Osiris Therapeutics Business Overview
Table 47:Osiris Therapeutics Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 48:Osiris Therapeutics Stem Cells Product Portfolio
Table 49:Osiris Therapeutics Recent Developments
Table 50:NuVasive Company Information
Table 51:NuVasive Business Overview
Table 52:NuVasive Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 53:NuVasive Stem Cells Product Portfolio
Table 54:NuVasive Recent Developments
Table 55:Chiesi Pharmaceuticals Company Information
Table 56:Chiesi Pharmaceuticals Business Overview
Table 57:Chiesi Pharmaceuticals Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 58:Chiesi Pharmaceuticals Stem Cells Product Portfolio
Table 59:Chiesi Pharmaceuticals Recent Developments
Table 60:Medi-post Company Information
Table 61:Medi-post Business Overview
Table 62:Medi-post Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 63:Medi-post Stem Cells Product Portfolio
Table 64:Medi-post Recent Developments
Table 65:JCR Pharmaceutical Company Information
Table 66:JCR Pharmaceutical Business Overview
Table 67:JCR Pharmaceutical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 68:JCR Pharmaceutical Stem Cells Product Portfolio
Table 69:JCR Pharmaceutical Recent Developments
Table 70:MolMed Company Information
Table 71:MolMed Business Overview
Table 72:MolMed Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 73:MolMed Stem Cells Product Portfolio
Table 74:MolMed Recent Developments
Table 75:Pharmicell Company Information
Table 76:Pharmicell Business Overview
Table 77:Pharmicell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 78:Pharmicell Stem Cells Product Portfolio
Table 79:Pharmicell Recent Developments
Table 80:Anterogen Company Information
Table 81:Anterogen Business Overview
Table 82:Anterogen Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 83:Anterogen Stem Cells Product Portfolio
Table 84:Anterogen Recent Developments
Table 85:Takeda (TiGenix) Company Information
Table 86:Takeda (TiGenix) Business Overview
Table 87:Takeda (TiGenix) Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 88:Takeda (TiGenix) Stem Cells Product Portfolio
Table 89:Takeda (TiGenix) Recent Developments
Table 90:CBR Company Information
Table 91:CBR Business Overview
Table 92:CBR Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 93:CBR Stem Cells Product Portfolio
Table 94:CBR Recent Developments
Table 95:ViaCord Company Information
Table 96:ViaCord Business Overview
Table 97:ViaCord Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 98:ViaCord Stem Cells Product Portfolio
Table 99:ViaCord Recent Developments
Table 100:Esperite Company Information
Table 101:Esperite Business Overview
Table 102:Esperite Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 103:Esperite Stem Cells Product Portfolio
Table 104:Esperite Recent Developments
Table 105:LifeCell Company Information
Table 106:LifeCell Business Overview
Table 107:LifeCell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 108:LifeCell Stem Cells Product Portfolio
Table 109:LifeCell Recent Developments
Table 110:CCBC Company Information
Table 111:CCBC Business Overview
Table 112:CCBC Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 113:CCBC Stem Cells Product Portfolio
Table 114:CCBC Recent Developments
Table 115:VCANBIO Company Information
Table 116:VCANBIO Business Overview
Table 117:VCANBIO Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 118:VCANBIO Stem Cells Product Portfolio
Table 119:VCANBIO Recent Developments
Table 120:BOYA LIFE Company Information
Table 121:BOYA LIFE Business Overview
Table 122:BOYA LIFE Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 123:BOYA LIFE Stem Cells Product Portfolio
Table 124:BOYA LIFE Recent Developments
Table 125:Beike Biotechnology Company Information
Table 126:Beike Biotechnology Business Overview
Table 127:Beike Biotechnology Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 128:Beike Biotechnology Stem Cells Product Portfolio
Table 129:Beike Biotechnology Recent Developments
Table 130:International Medical Company Information
Table 131:International Medical Business Overview
Table 132:International Medical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 133:International Medical Stem Cells Product Portfolio
Table 134:International Medical Recent Developments
Table 135:Authors List of This Report
Figure 1:Research Methodology
Figure 2:Research Process
Figure 3:Key Executives Interviewed
Figure 4:Stem Cells Product Image
Figure 5:Global Stem Cells Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 6:Global Stem Cells Market Share by Type: 2024 VS 2031
Figure 7:Stem Cell Storage Product
Figure 8:Stem Cell Pharmaceutical and Treatment Product
Figure 9:Global Stem Cells Market Size by Application (2025-2031) & (US$ Million)
Figure 10:Global Stem Cells Market Share by Application: 2024 VS 2031
Figure 11:Diseases of the Central Nervous System Product
Figure 12:Cardiovascular Disease Product
Figure 13:Diabetes Product
Figure 14:Cancer Product
Figure 15:Genetic Diseases Product
Figure 16:Autoimmune Disease Product
Figure 17:Bone and Cartilage Repair Product
Figure 18:Other Product
Figure 19:Global Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20:Global Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21:Global Stem Cells Market Share by Region: 2024 VS 2031
Figure 22:Global Stem Cells Market Share by Players in 2024
Figure 23:Global Stem Cells Manufacturers Established Date
Figure 24:Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2024
Figure 25:Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26:North America Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27:North America Stem Cells Market Share by Country (2020-2031)
Figure 28:United States Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29:Canada Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30:Mexico Stem Cells Market Share by Country (2020-2031)
Figure 31:Europe Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32:Europe Stem Cells Market Share by Country (2020-2031)
Figure 33:Germany Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34:France Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35:U.K. Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36:Italy Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37:Spain Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38:Russia Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39:Netherlands Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40:Nordic Countries Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41:Asia-Pacific Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42:Asia-Pacific Stem Cells Market Share by Country (2020-2031)
Figure 43:China Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44:Japan Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45:South Korea Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46:India Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47:India Stem Cells Market Share by Country (2020-2031)
Figure 48:Australia Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49:China Taiwan Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50:Southeast Asia Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51:South America Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52:South America Stem Cells Market Share by Country (2020-2031)
Figure 53:Brazil Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54:Argentina Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55:Chile Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56:Colombia Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57:Peru Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58:Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 59:NuVasive Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 60:Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 61:Medi-post Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 62:JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 63:MolMed Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 64:Pharmicell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 65:Anterogen Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 66:Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 67:CBR Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 68:ViaCord Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 69:Esperite Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 70:LifeCell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 71:CCBC Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 72:VCANBIO Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 73:BOYA LIFE Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 74:Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 75:International Medical Revenue Growth Rate in Stem Cells Business (2020-2025)

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Medical Care

Stem Cells Industry Research Report 2025

0| 0 Reviews

Pages: 132

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.